Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fleischer

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Neurological Disorders|February 13, 2024
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, et al.
Neurologia I Neurochirurgia Polska|June 21, 2022
Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patientsMichael Fleischer, Helene Schuh, Nela M Bickmann, et al.
Der Nervenarzt|March 7, 2022
[Essen transition model for neuromuscular diseases]Michael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Frontiers in Neurology|December 3, 2019
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular AtrophyKathrin Kizina, Benjamin Stolte, Andreas Totzeck, et al.
Neurological Research and Practice|September 4, 2022
Essen transition model for neuromuscular diseasesMichael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Journal of Neuroinflammation|April 9, 2021
Corneal confocal microscopy differentiates inflammatory from diabetic neuropathyMichael Fleischer, Inn Lee, Friedrich Erdlenbruch, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 3, 2020
NK cell markers predict the efficacy of IV immunoglobulins in CIDPAnne K Mausberg, Maximilian K Heininger, Gerd Meyer Zu Horste, et al.
Neurology and Therapy|May 13, 2022
COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional StudyVenja Musche, Alexander Bäuerle, Lisa Jahre, et al.
Neurological Research and Practice|December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areasAndreas Thimm, Saskia Bolz, Michael Fleischer, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|February 13, 2024
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, et al.
Neurologia I Neurochirurgia Polska|June 21, 2022
Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patientsMichael Fleischer, Helene Schuh, Nela M Bickmann, et al.
Der Nervenarzt|March 7, 2022
[Essen transition model for neuromuscular diseases]Michael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Frontiers in Neurology|December 3, 2019
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular AtrophyKathrin Kizina, Benjamin Stolte, Andreas Totzeck, et al.
Neurological Research and Practice|September 4, 2022
Essen transition model for neuromuscular diseasesMichael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Journal of Neuroinflammation|April 9, 2021
Corneal confocal microscopy differentiates inflammatory from diabetic neuropathyMichael Fleischer, Inn Lee, Friedrich Erdlenbruch, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 3, 2020
NK cell markers predict the efficacy of IV immunoglobulins in CIDPAnne K Mausberg, Maximilian K Heininger, Gerd Meyer Zu Horste, et al.
Neurology and Therapy|May 13, 2022
COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional StudyVenja Musche, Alexander Bäuerle, Lisa Jahre, et al.
Neurological Research and Practice|December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areasAndreas Thimm, Saskia Bolz, Michael Fleischer, et al.
Pageof 3